What this ad does well
The split screen and "by winter" caption combine an outcome picture with a timeline, so the viewer gets the promise in the first second. Hers ties the hook to what's new (the voiceover calls it the first FDA-approved GLP-1 in a pill), which gives a reason to look now rather than someday. The trial claims are footnoted on screen, including the average result alongside the "up to" figure and a note that stopping treatment may result in weight regain. Ending on a quiz screen asking how much weight you want to lose previews the next step.
What's missing
The split screen is labeled as actor portrayals, so the visual that carries the hook isn't a real result, and the "up to 20%" line is bigger and louder than the average the footnote gives. The ad also previews a weight-goal question that isn't the first question on the landing page. If you make one like this, lead with the average figure in the caption and keep the "up to" claim in the footnote, so the promise matches what most people can expect. Then make the quiz screen in the ad match the first screen visitors will actually see.
Beat by beat
- 0-3s
A split screen of two actors with the caption "This is what 1 pill a day can do by winter" and an actor-portrayals label.It sets a visual outcome and a seasonal timeline in one frame.
- 3-12s
The voiceover introduces the first FDA-approved GLP-1 in a pill and an up-to-20% figure, with trial footnotes on screen.It ties the hook to a newsworthy product and attributes the claim to a clinical study.
- 12-20s
Captions say clinically proven and once a day, over the pill and its packaging, with the regain note.It shows the product and the daily routine while keeping the safety context visible.
- 20-26s
Captions list no insurance, no in-person visits, 100% online, and that the sooner you start the sooner you see results.It removes access barriers and adds a reason not to wait.
- 26-30s
Take the online consultation, then a quiz screen asking how much weight you want to lose.It previews the first step so the click feels simple.
The offer
The copy lists medication as low as $149 a month if prescribed, plus a membership of $39 for the first month and $149 after; the headline is Get started today with free shipping.
Where it sends people
It lands on Hers's Wegovy consultation entry, which 53 ads in the Fluid library point to. That's close to the quiz end of the ladder: the hero holds the first intake question in a card with a three-step indicator, asking whether the visitor already has a treatment in mind, with two format answers and a provider-recommendation answer. The options carousel with "from" monthly prices and the dosing schedule pick up this ad's pill story further down. The mismatch is at the top: the video ends on a weight-goal question, while the page opens on whether you have a treatment in mind.
The page it sends people to: How Hers starts its Wegovy consultation inside the page hero
Hers's Wegovy consultation page opens with the first intake question in a card over the hero, then scrolls through medication cards with "from" monthly prices, a results band, membership perks, a dosing schedule and a long FAQ. 53 ads in the Fluid library send people here, including price-led, food-noise, membership-value and creator-story ads.
How the page is built
- 01
Announcement bar and headerA single line on affordability sits above a logo-only header, so the price question gets a nod before anything else and there's no navigation to wander off into.
- 02
Hero with intake cardA full-bleed portrait with a descending line-graph overlay frames a centered card that asks whether the visitor already has a treatment in mind, answering "where do I start?" with three one-tap choices.
- 03
Options carouselHorizontal medication cards show the product, prescription and availability tags, a "from" monthly price and a safety link, answering "what are my options and what do they cost?" with pricing and eligibility fine print below.
- 04
Results bandAn outdoor photo of two women carries a headline, three check items and a frosted card with a large outcome figure, which is the page's main answer to "what could this look like for me?"
- 05
MembershipA four-photo collage (provider, app, product, smart scale) sits over five check-row perks, answering "what am I paying the membership for?"
- 06
Health-marker carouselDark cards pair data-visualization illustrations with short benefit claims and footnotes, covering what the page says treatment can involve beyond the scale.
- 07
Dosing scheduleA chart of example monthly dose increases and a numbered four-step accordion with dose pills explain how treatment eases in, answering "what happens month to month?"
- 08
FAQA long accordion covers membership, cost, options, visits, insurance, HSA, eligibility, switching and side effects, catching the practical objections that are left.
- 09
FooterDisclaimers, an app-download card with a QR code, a pharmacy certification badge and a sister-brand card close the page with trust signals and legal detail.
The first fixes we would make
- The membership fee is separate from the medication price, and that detail lives in fine print under the carousel. Put the combined monthly cost (medication plus membership) right under each "from" price, so a visitor who came from a price ad sees the number they'll actually pay before they start the intake.
- Creator-story ads send people here, but the page has no member stories or reviews to pick up that voice; the results band shows a single outcome figure instead. Add a short strip of member stories (with the same disclaimers Hers uses elsewhere) near the results band, so someone who clicked a creator's documentary finds people like that creator on the page.
Read the full breakdown of this page
Three hooks you could test
- Sell the outcome. “Here's what one small daily habit can do by the holidays.”
- Call out the habit you're replacing. “No needles, no waiting room, just one pill a day.”
- Show a specific moment of use. “Take it with your morning coffee and get on with your day.”
What to borrow for your brand
- Pair an outcome caption with a season or date in the first frame, so the promise carries its own urgency.
- Keep claim footnotes on screen during the line that makes the claim, so accuracy travels with the hook.
- End the video on the exact first screen of your quiz, so the visitor recognizes it when they land.
Transcript
This is what one pill a day can do by winter. You can get the 1st FDA approved GLP1 in a pill for weight loss and lose up to 20% of your body weight, clinically proven to promote weight loss and taken only once a day. No injection needed, no insurance required. No in-person visits, just 100% online, thanks to the once daily We Govi pill with hers. The sooner you start, the sooner you start seeing results. Take the online consultation to get started.
Text on screen
- This is what1 pilla day
- can do by winter
- Actor portrayals
- You could get the first
- FDA-approved
- GLP-1 in a pill for
- weight loss
- wegovy: 1.5 mg
- And lose up to 20% of
- your body weight*
- People lost an average of 14% body weight
- at 64 weeks in a clinical trial of Wegovy®
- *in a 7h-week dinical study of Wegory" oril semagluide (25mg), 279% of adults with overweight
- or obesity lost 220% body weight at week 64, alongside diet and exercise Individual results may vary.
- Stopping treatment may result in weight regain.
- Future you thanks you.
- Clinically proven to promote weight
- loss,* and taken only once a day
- *In a 71-week clinical study of Wegovy" oral semaglitide (25mg) adults with overweight of obesity
- lost on avg, 13.6% body-
- sight albegside diet and marcal individual results may vary.
- Stopping treatment may result in weight regain
- himss hers
- NDC 0145-4425-31
- (sem
- glutide) Tablets
- Rx only
- loss, "and taken only/once a day
- *In a 71-week dinical study of Wegory" oral seraglutie (25mg), adults with overweight or obesity
- lost on avg. 13.6% body wight alongside diet and earcit Individual results may vary.
- Stopping treatment may result in weight regah.
- loss,® and taken only once a day
- "in a 71-week clinical study of Wegovy* oral semaglutide (25mg), aduits with overweight or obesity
- lost on avg. 13.6% body weight alongside diet and mercie, Individual results mayvary
- No insurance required
- No in-person visits
- Just 100% online
- Thanks to the once-daily
- Wegovy® Pill with Hers
- The sooner you start
One of 125 Hers ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 20, 2026. We record that an ad ran publicly, not how it performed.